Curr Ther Res Clin Exp. 2007 Sep;68(5):303-12. doi: 10.1016/j.curtheres.2007.10.003.
Effects of ondansetron and granisetron on postoperative nausea and vomiting in adult patients undergoing laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled clinical trial.
Current therapeutic research, clinical and experimental
Azize Bestas, Selami Ates Onal, Mustafa Kemal Bayar, Asli Yildirim, Erhan Aygen
Affiliations
Affiliations
- Department of Anesthesiology and Reanimation, Firat University School of Medicine, Elazig, Turkey.
- Harput State Hospital, Elazig, Turkey.
- Department of General Surgery, Firat University School of Medicine, Elazig, Turkey.
PMID: 24692762
PMCID: PMC3969949 DOI: 10.1016/j.curtheres.2007.10.003
Abstract
BACKGROUND: Postoperative nausea and vomiting (PONV) are common and potentially distressing adverse events (AEs) associated with surgery and anesthesia. In patients undergoing laparoscopic cholecystectomy (LC) without antiemetic prophylaxis, the incidence of PONV can be as high as 72%.
OBJECTIVE: The aim of this study was to investigate the prophylactic antiemetic effects of ondansetron and granisetron in patients undergoing LC when these agents are administered before the end of surgery.
METHODS: Patients classified by the American Society of Anesthesiologist's physical status as I or II who were scheduled for elective LC were included in this randomized, double-blind, placebo-controlled study. Anesthesia was induced with thiopental 5 mg/kg and fentanyl 2 μg/kg, and was maintained with isoflurane 1% to 3% in 50% oxygen and 50% nitrous oxide and fentanyl as needed. Approximately 20 to 30 minutes before the end of the surgery, the patients randomly received either IV ondansetron 100 μg/kg (group O), IV granisetron 40 μg/kg (group G), or normal saline (group P). Plasma levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined preoperatively and 24 hours postoperatively. The patients were observed for 24 hours for PONV and other possible AEs. Postoperative pain intensity was determined using a 10-cm visual analogue scale. Four-point satisfaction scores were determined at 24 hours.
RESULTS: Ninety patients (69 women, 21 men) participated in the study. Demographic characteristics and operative data (duration of surgery and anesthesia and amount of intraoperative fentanyl) were similar in the 3 groups. The only AE reported by patients during the 24-hour observation period was nonsevere headache. The number of patients experiencing headache was similar in group P, group O, and group G (10 [33%] patients, 6 [20%], and 10 [33%], respectively). No significant changes were found in presurgical and postsurgical plasma levels of ALT and AST in any group. The mean (SD) satisfaction scores in group O and group G (3.0 [0.4] and 3.0 [0.6], respectively) were significantly higher than those in group P (2.5 [0.5]; both, P < 0.01). Immediately after surgery (period 0), significantly more patients in the placebo group (21 [70%]) experienced PONV compared with those in the ondansetron group (9 [30%]; P < 0.05) and the granisetron group (7 [23%]; P < 0.01). During the 24-hour observation period, a significantly greater number of patients in group P (18 [60%]) required a single dose of a rescue antiemetic drug compared with those in groups O and G (9 [30%] and 6 [20%], respectively; both, P < 0.01).
CONCLUSIONS: Patients administered ondansetron 100 μg/kg or granisetron 40 μg/kg 20 to 30 minutes before the end of LC had significantly higher PONV control during the 24-hour postoperative observation period than patients receiving placebo. However, there were no significant differences between the active treatment groups in the incidence of PONV, patient satisfaction, or AEs.
Keywords: granisetron; laparoscopic cholecystectomy; ondansetron; postoperative nausea and vomiting
References
- J Clin Anesth. 1997 Dec;9(8):658-63 - PubMed
- Surg Endosc. 2002 Feb;16(2):286-8 - PubMed
- J Clin Gastroenterol. 1994 Dec;19(4):325-30 - PubMed
- Anesth Analg. 2000 Jun;90(6):1352-8 - PubMed
- Clin Ther. 2003 Apr;25(4):1142-9 - PubMed
- Drugs. 1991 Apr;41(4):574-95 - PubMed
- Can J Anaesth. 1996 Mar;43(3):226-31 - PubMed
- Anesth Analg. 1998 Feb;86(2):274-82 - PubMed
- J Clin Anesth. 1997 Sep;9(6):451-6 - PubMed
- J Clin Anesth. 1999 Sep;11(6):453-9 - PubMed
- Eur J Anaesthesiol. 1998 May;15(3):287-91 - PubMed
- Anesth Analg. 1995 May;80(5):970-4 - PubMed
- Acta Anaesthesiol Scand. 1997 Oct;41(9):1167-70 - PubMed
- Drugs. 2000 Feb;59(2):213-43 - PubMed
- Drug Saf. 2003;26(4):227-59 - PubMed
- Anesthesiology. 1997 Dec;87(6):1277-89 - PubMed
- Acta Anaesthesiol Scand. 2002 Jan;46(1):109-13 - PubMed
- Br J Anaesth. 1998 Oct;81(4):526-8 - PubMed
- Can J Anaesth. 1994 Sep;41(9):794-7 - PubMed
Publication Types